Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I/II Idasanutlin w/ Ixazomib and dexamethasone in patients with 17p deleted, relapsed MM

Protocol: OSU-16015

Full Title

Phase I/II trial of Idasanutlin in combination with Ixazomib and dexamethasone in patients with 17p deleted, relapsed multiple myeloma